Curcumin in Patients With Mild to Moderate Alzheimer's Disease
Completed · Phase 2
Conditions studied: Alzheimer's Disease
In brief
The purpose of this study is to examine the safety and tolerability of curcumin, and to determine its effect on patients with mild to moderate Alzheimer's Disease (AD).
Key facts
- Study ID
- NCT00099710
- Run by
- John Douglas French Foundation
- People needed
- 33
- Starts
- 2003-07-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2009-12-03
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female at least 50 years old
- Diagnosis of probable AD
- No history of significant psychiatric or non-AD neurological disease
- Proficient in English to be able to perform cognitive testing
- Caregiver available to monitor and administer medication and to accompany patient to every clinical visit
- On stable doses of cholinesterase inhibitors and memantine (Alzheimer's medications) for 3 months prior to enrollment
- On stable doses of all other allowed medications for at least one month prior to starting the study medication
You may not qualify if…
- Current or recent major psychiatric illness (i.e. bipolar disorder, schizophrenia)
- Significant, uncontrolled systemic illness (i.e. chronic renal failure, chronic liver disease, poorly controlled diabetes, or poorly controlled congestive heart failure)
- Recent history of gastrointestinal bleeding or ulceration
- Alcoholism or substance abuse within the past year
- Familial, autosomal dominant Alzheimer's disease due to a mutation in a known gene (Presenilin-1, Presenilin-2, or Amyloid Precursor Protein)
- NSAIDs (e.g. ibuprofen, naproxen, etc.) taken on a regular basis (more than 3 times per week)
- Aspirin at doses more than 325 mg per day
- Coumadin, heparin, other anticoagulants
- Antioxidants or other supplements including gingko biloba, coenzyme Q10, alpha-lipoic acid
- Vitamin E at doses more than 2,000 IU per day
- Vitamin C at doses more than 500 mg per day
Where it is running
- UCLA Medical Center — Westwood, Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.